Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis
BACKGROUND: Diabetes mellitus is a possible risk factor for the development of idiopathic pulmonary fibrosis (IPF), yet the effect of antidiabetic therapy on the course of IPF is unknown. - OBJECTIVES: This post hoc analysis assessed the effect of metformin on clinically relevant outcomes in patient...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
October 2018
|
| In: |
Respiration
Year: 2018, Volume: 96, Issue: 4, Pages: 314-322 |
| ISSN: | 1423-0356 |
| DOI: | 10.1159/000489668 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000489668 Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/489668 
|
| Author Notes: | Paolo Spagnolo, Michael Kreuter, Toby M. Maher, Wim Wuyts, Francesco Bonella, Tamera J. Corte, Stefan Kopf, Derek Weycker, Klaus-Uwe Kirchgaessler, Christopher J. Ryerson |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1693710153 | ||
| 003 | DE-627 | ||
| 005 | 20241223012239.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200401s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000489668 |2 doi | |
| 035 | |a (DE-627)1693710153 | ||
| 035 | |a (DE-599)KXP1693710153 | ||
| 035 | |a (OCoLC)1341312922 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Spagnolo, Paolo |e VerfasserIn |0 (DE-588)1207412783 |0 (DE-627)1693711273 |4 aut | |
| 245 | 1 | 0 | |a Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis |c Paolo Spagnolo, Michael Kreuter, Toby M. Maher, Wim Wuyts, Francesco Bonella, Tamera J. Corte, Stefan Kopf, Derek Weycker, Klaus-Uwe Kirchgaessler, Christopher J. Ryerson |
| 264 | 1 | |c October 2018 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.04.2020 | ||
| 520 | |a BACKGROUND: Diabetes mellitus is a possible risk factor for the development of idiopathic pulmonary fibrosis (IPF), yet the effect of antidiabetic therapy on the course of IPF is unknown. - OBJECTIVES: This post hoc analysis assessed the effect of metformin on clinically relevant outcomes in patients with IPF. - METHODS: For the primary analysis, patients randomized to placebo (n = 624) in 3 phase 3, double-blind, controlled trials of pirfenidone (CAPACITY [NCT00287716 and NCT00287729]; ASCEND [NCT01366209]) were categorized by baseline metformin use. The primary outcome was disease progression (forced vital capacity [FVC] decline ≥10%, 6-min walking distance [6MWD] decline ≥50 m, or death). Other outcomes included mortality, hospitalization, FVC decline (≥10 and ≥5%), and 6MWD decline. Outcomes were also assessed in patients with diabetes and/or hyperglycemia (impaired glucose tolerance [IGT] and diabetes population [IGT-diabetes population]) and all patients included in the 3 studies (intention-to-treat [ITT] population). - RESULTS: Overall, 71 (11.4%) patients were metformin users and 553 (88.6%) were nonmetformin users. Baseline data were similar between groups, except for a higher percentage of males (84.5 vs. 73.2%) and a history of diabetes (98.6 vs. 11.6%) in metformin users versus nonmetformin users. The unadjusted 1-year analyses demonstrated no significant differences in disease progression or other outcomes. A higher proportion of metformin users compared with nonmetformin users had a relative FVC decline of ≥5% (63.4 vs. 50.6%, p = 0.043). Results were similar for the IGT-diabetes population and for the ITT population. Multivariable analyses yielded similar results. - CONCLUSIONS: Metformin has no effect on clinically relevant outcomes in patients with IPF. | ||
| 650 | 4 | |a Aged | |
| 650 | 4 | |a Anti-Inflammatory Agents, Non-Steroidal | |
| 650 | 4 | |a Diabetes mellitus | |
| 650 | 4 | |a Diabetes Mellitus | |
| 650 | 4 | |a Disease Progression | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Hyperglycemia | |
| 650 | 4 | |a Hypoglycemic Agents | |
| 650 | 4 | |a Idiopathic pulmonary fibrosis | |
| 650 | 4 | |a Idiopathic Pulmonary Fibrosis | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Metformin | |
| 650 | 4 | |a Middle Aged | |
| 650 | 4 | |a Post hoc analysis | |
| 650 | 4 | |a Pyridones | |
| 650 | 4 | |a Vital Capacity | |
| 700 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 700 | 1 | |a Maher, Toby M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wuyts, Wim |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Bonella, Francesco |e VerfasserIn |0 (DE-588)1188737015 |0 (DE-627)166764534X |4 aut | |
| 700 | 1 | |a Corte, Tamera J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kopf, Stefan |d 1978- |e VerfasserIn |0 (DE-588)1013047516 |0 (DE-627)663343453 |0 (DE-576)346399025 |4 aut | |
| 700 | 1 | |a Weycker, Derek |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kirchgaessler, Klaus-Uwe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ryerson, Christopher J. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiration |d Basel : Karger, 1968 |g 96(2018), 4, Seite 314-322 |h Online-Ressource |w (DE-627)26551035X |w (DE-600)1464419-8 |w (DE-576)112815111 |x 1423-0356 |7 nnas |a Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis |
| 773 | 1 | 8 | |g volume:96 |g year:2018 |g number:4 |g pages:314-322 |g extent:9 |a Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000489668 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.karger.com/Article/FullText/489668 |x Verlag |z lizenzpflichtig |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20200401 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1013047516 |a Kopf, Stefan |m 1013047516:Kopf, Stefan |d 910000 |d 910100 |e 910000PK1013047516 |e 910100PK1013047516 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1693710153 |e 3617179061 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Paolo Spagnolo, Michael Kreuter, Toby M. Maher, Wim Wuyts, Francesco Bonella, Tamera J. Corte, Stefan Kopf, Derek Weycker, Klaus-Uwe Kirchgaessler, Christopher J. Ryerson"]},"origin":[{"dateIssuedDisp":"October 2018","dateIssuedKey":"2018"}],"id":{"eki":["1693710153"],"doi":["10.1159/000489668"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"title":[{"subtitle":"international journal of thoracic medicine","title":"Respiration","title_sort":"Respiration"}],"disp":"Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosisRespiration","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1968-","publisher":"Karger","publisherPlace":"Basel","dateIssuedKey":"1968"}],"id":{"issn":["1423-0356"],"zdb":["1464419-8"],"eki":["26551035X"]},"part":{"pages":"314-322","year":"2018","extent":"9","text":"96(2018), 4, Seite 314-322","issue":"4","volume":"96"},"recId":"26551035X","note":["Gesehen am 03.07.2024"],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["Vol. 25, no. 1 (1968)-"]}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Paolo","display":"Spagnolo, Paolo","family":"Spagnolo"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Michael","display":"Kreuter, Michael","family":"Kreuter"},{"family":"Maher","given":"Toby M.","role":"aut","roleDisplay":"VerfasserIn","display":"Maher, Toby M."},{"role":"aut","roleDisplay":"VerfasserIn","given":"Wim","display":"Wuyts, Wim","family":"Wuyts"},{"display":"Bonella, Francesco","given":"Francesco","role":"aut","roleDisplay":"VerfasserIn","family":"Bonella"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Tamera J.","display":"Corte, Tamera J.","family":"Corte"},{"display":"Kopf, Stefan","given":"Stefan","roleDisplay":"VerfasserIn","role":"aut","family":"Kopf"},{"family":"Weycker","given":"Derek","role":"aut","roleDisplay":"VerfasserIn","display":"Weycker, Derek"},{"family":"Kirchgaessler","given":"Klaus-Uwe","role":"aut","roleDisplay":"VerfasserIn","display":"Kirchgaessler, Klaus-Uwe"},{"display":"Ryerson, Christopher J.","role":"aut","roleDisplay":"VerfasserIn","given":"Christopher J.","family":"Ryerson"}],"language":["eng"],"title":[{"title_sort":"Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis","title":"Metformin does not affect clinically relevant outcomes in patients with idiopathic pulmonary fibrosis"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 01.04.2020"],"recId":"1693710153"} | ||
| SRT | |a SPAGNOLOPAMETFORMIND2018 | ||